We examined Epstein-Barr virus (EBV)-specific antibodies in serum samples from 64 and 59 patients with EBV-positive and -negative gastric carcinomas, respectively, and 73 healthy controls using immunofluorescence assays. EBV capsid antigen (VCA) IgG and EBV-determined nuclear antigen (EBNA) IgG were
Epstein-barr virus-specific serodiagnostic tests in carcinomas of the head and neck
β Scribed by Ulrik Ringborg; Werner Henle; Gertrude Henle; Snorri Ingimarsson; George Klein; Claes Silfversward; Hans Strander
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 633 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract In order to better understand the relationship between IgA and IgG antibodies to EpsteinβBarr virus (EBV) in nasopharyngeal carcinoma (NPC), we analyzed 230 NPC sera but also a series of sera from patients with other carcinomas selected for their high EBV/IgG antibody titres. We were su
## Abstract Seven American juvenile patients with undifferentiated or nonkeratinizing nasopharyngeal carcinoma (NPC) were examined serially for EpsteinβBarr virus (EBV)βspecific antibody spectra and titers in sera. At diagnosis, all showed antibody patterns characteristic of NPC: __i.e.__, high tit
Antibody against Epstein Barr Viral capsid (EBV-VCA) was measured in 65 patients with primary head and neck cancer referred for radical radiotherapy. Sixty-three percent had locally advanced cancer and 37% had early disease. Forty-eight percent had detectable antibody in their sera. Thirty-three per
## Background: Reports that have both evaluated the site-specific epstein-barr virus (ebv) infection and compared it with the expression of the ebv-related proto-oncogenes and tumor suppressor genes in the various cancers of head and neck are scarce. ## Methods: Thirty-eight nasopharyngeal carcin